Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis

The Pathogenesis of Adenomyosis vis-à-vis Endometriosis

(2020) Guo   Journal of Clinical Medicine

Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment

(2020) P Peuranpää et al.   HUMAN REPRODUCTION

Evidence in Support for the Progressive Nature of Ovarian Endometriomas

(2020) Ding Ding et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis

(2020) Nicola Pluchino et al.   FERTILITY AND STERILITY

Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis

(2019) Dingmin Yan et al.   Scientific Reports

Genesis, genes and epigenetics of endometriosis-associated infertility

(2019) Sun-Wei Guo   Nature Reviews Endocrinology

Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity

(2019) Malcolm G. Munro   FERTILITY AND STERILITY

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis

(2019) Fahad T. Alotaibi et al.   PLoS One

Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology

(2019) Yuqian Xiang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Classification and Reporting Systems for Adenomyosis

(2019) Malcolm G. Munro   Journal of Minimally Invasive Gynecology

Plasminogen activator inhibitor-1 in cancer research

(2018) Sijing Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Pathogenesis of uterine adenomyosis: invagination or metaplasia?

(2018) Javier García-Solares et al.   FERTILITY AND STERILITY

OUP accepted manuscript

(2018)   HUMAN REPRODUCTION UPDATE

OUP accepted manuscript

(2018)   HUMAN REPRODUCTION

Time to redefine endometriosis including its pro-fibrotic nature

(2017) P Vigano et al.   HUMAN REPRODUCTION

Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis

(2017) Reyhaneh Rabieian et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Association Between Early Participation in Physical Activity Following Acute Concussion and Persistent Postconcussive Symptoms in Children and Adolescents

(2016) Anne M. Grool et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis

(2016) Christopher N. Herndon et al.   Reproductive Sciences

The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis

(2016) Panagiotis Flevaris et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Prevalence of adenomyosis in women undergoing surgery for endometriosis

(2014) Nadine Di Donato et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Structural and molecular features of the endomyometrium in endometriosis and adenomyosis

(2013) Giuseppe Benagiano et al.   HUMAN REPRODUCTION UPDATE

Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes

(2012) Abha Maheshwari et al.   HUMAN REPRODUCTION UPDATE

Tissue factor–protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation

(2011) Leylla Badeanlou et al.   NATURE MEDICINE

Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis

(2010) Jichan Nie et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis

(2010) X. Liu et al.   HUMAN REPRODUCTION

Immunoreactivity of progesterone receptor isoform B, nuclear factor κB, and IκBα in adenomyosis

(2009) Jichan Nie et al.   FERTILITY AND STERILITY

The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases

(2009) Hunjoo Ha et al.   Nature Reviews Nephrology